Tuesday that biotech drug maker Amgen Inc Division of Justice said.
Amgen agrees to $25M settlement after kickback allegations The biotech drug maker was accused of paying kickbacks to increase sales of its anemia drug Aranesp priligy-online.html .S. Tuesday that biotech drug maker Amgen Inc Division of Justice said. Will pay $24.9 million to solve claims it paid kickbacks to improve sales of its anemia drug Aranesp. The Justice Department stated Amgen paid kickbacks to Omnicare Inc. And PharMerica Corp., which offer drugs to long-term treatment providers such as nursing hospitals and homes, and Kindred Health care Inc., which runs long-term acute-care hospitals and nursing and rehabilitation centers . Related StoriesCholinesterase inhibitor delays nursing home admission in late-stage ADNew study can lead to effective treatment to avoid common chemotherapy unwanted effects in tumor patientsBystander CPR can prevent brain damage, nursing home admission following cardiac arrest And Johnson & Johnson reported its first quarter revenue are down – – The Associated Press/Washington Post: Johnson & Johnson's 1Q Profit Straight down 10.